Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Bora
Dilip Chandra Bora, Assam IN
| Patent application number | Description | Published |
|---|---|---|
| 20130131350 | PYRIDIN-2YL SULFANYL ACID ESTERS AND PROCESS FOR THE PREPARATION THEREOF - The present invention relates to Pyridin-2-yl sulfanyl acid ester compounds having antiinflammatory properties. The present invention particularly relates to novel anti-inflammatory heterocyclic acid esters of Pyridin-2-yl sulfanyl having the structure of general formula 1 which have been screened for their antiinflammatory activity with respect to inhibition of adhesion of neutrophils, isolated from human peripheral blood, onto the surface of human umbilical vein endothelial cells (HU-VEC) as a result of inhibition of the cytokine-stimulated expression of cell adhesion molecule ICAM-1. The compound RS—Z, 3-(Pyridin-2-yl sulfanyl)-propionic acid pentyl ester (structure 1a, R | 05-23-2013 |
Divyakumar Hemant Bora, Vadodara IN
| Patent application number | Description | Published |
|---|---|---|
| 20130034604 | EXTENDED RELEASE FORMULATIONS OF DESVENLAFAXINE BASE - An extended release pharmaceutical composition comprising micronized desvenlafaxine base, at least one pH modifier and at least one release controlling agent and its process for preparation. An extended release monolithic tablet is also provided. Further extended release tablets comprising micronized desvenlafaxine base; at least one pH modifier; at least one release controlling agent; and at least one binder; wherein, the proportion of binder in the tablet is greater than about 3.0% of the total weight of the tablet and wherein, the pH modifier is present in a proportion of more than about 15 parts for each of the 100 parts of the desvenlafaxine base is also provided. Also provided is process for preparation of extended release tablet. | 02-07-2013 |
Luca Bora, Civitanova Marche IT
| Patent application number | Description | Published |
|---|---|---|
| 20090277200 | REFRIGERATION UNIT AND RESPECTIVE CONTROL AND MANAGEMENT ASSEMBLY - A refrigeration unit and a respective control and management assembly, comprising a refrigeration assembly and at least one power input for its electrical power supply. The refrigeration unit comprising at least one signal input and at least one control switch, which is arranged along a power line which corresponds to the power input. The control switch controlling the power line and the data that arrive from the respective signal input being suitable for driving the control switch for consequently determining the presence/absence of electrical power supply for said refrigeration assembly. | 11-12-2009 |
Mihail Bora, Livermore, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100328671 | NEAR FIELD DETECTOR FOR INTEGRATED SURFACE PLASMON RESONANCE BIOSENSOR APPLICATIONS - A near-field surface plasmon detector is provided. The near-field surface plasmon detector includes one or more semiconductor layers that absorb one or more surface plasmons of thin metal films in the vicinity of the semiconductor layer. The surface plasmons are excited by incoming light being emitted from a light emitting source. The metal films are also employed as electrical contacts used to capture photocurrent generated after absorption of surface plasmons by the semiconductor layers. | 12-30-2010 |
| 20120224255 | PLASMON RESONANT CAVITIES IN VERTICAL NANOWIRE ARRAYS - Tunable plasmon resonant cavity arrays in paired parallel nanowire waveguides are presented. Resonances can be observed when the waveguide length is an odd multiple of quarter plasmon wavelengths, consistent with boundary conditions of node and antinode at the ends. Two nanowire waveguides can satisfy the dispersion relation of a planar metal-dielectric-metal waveguide of equivalent width equal to the square field average weighted gap. Confinement factors of over 10 | 09-06-2012 |
Mumtaz Y. Bora, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100270066 | PRINTED CIRCUIT BOARD DESIGN SYSTEM AND METHOD - A printed circuit board (PCB) design system and method allows for PCB layouts that can be manufactured using a PCB manufacturing technology selected from multiple PCB manufacturing technologies with minimal or no modification to the PCB layout. Accordingly, a PCB layout of a PCB meets the requirements, or nearly meets the requirements, for multiple manufacturing technology design rules. In accordance with the exemplary embodiment, the PCB layout is designed to meet all design rules of a High Density Interconnect (HDI) manufacturing technology while minimizing requirements for layout changes when the PCB is manufactured using an Interstitial Via Hole (IVH) manufacturing technology. An IVH PCB includes a plurality of vias positioned within reserved via areas that form connections between at least some conductive elements on the board layers. The conductive elements and the plurality of vias form a layout such that a majority of reserved via areas, of all of the reserved via areas on the printed circuit board, are adequate to accommodate mechanically drilled vias manufactured in accordance with the HDI manufacturing technology. | 10-28-2010 |
Nalini Bora, Little Rock, AR US
Nalini S. Bora, Little Rock, AR US
| Patent application number | Description | Published |
|---|---|---|
| 20080221030 | Inhibition of Wet Type Age Related Macular Degeneration (Amd) by Adiponectin or Acrp 30 - The present invention provides new methods of treating wet type of age related macular degeneration by administering adiponectin (APN) or a functional fragment derived therefrom. One of the pathological complications of age related macular degeneration (AMD) is choroidal angiogenesis or choroidal neovascularization (CNV). The inventors discovered that the level of APN expression is significantly lower in the choroids of the laser-induced mouse model of choroidal angiogenesis or choroidal neovascularization (CNV) than that of the control mice and that administration of recombinant adiponectin (rAPN) or a peptide derived from the globular domain of the intact APN protein to the mouse model of CNV reduced the size of CNV significantly. These studies are the first to demonstrate the inhibitory effect of adiponectin on choroidal angiogenesis and thus provide the basis for treating a condition or disease involving angiogenesis, particularly age related macular degeneration, with administration of adiponectin. | 09-11-2008 |
| 20120041074 | Method of inducing neovascularization - A method for inducing neovascularization in which a pharmaceutically effective amount of polyethylene glycol (PEG) is injected into the tissue of the subject for purposes of accelerating wound healing and mimicking age related macular degeneration, cancer, tumors, and atherosclerosis for further research purposes. | 02-16-2012 |
Prachi Bora, Bellevue, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20100275137 | OPENING NETWORK-ENABLED ELECTRONIC DOCUMENTS - System(s), method(s), and/or technique(s) (“tools”) are described that enable a user to open a network-enabled electronic document in either a specific software application associated with the electronic document or a network browser. In some cases the tools do so using a single link On selection of the link, if the user's computing device has access to the specific software application, the tools may load the electronic document using that application. Or, if the user's computing device does not have access to the specific software application, the tools may render the electronic document with a network browser. In so doing, the tools may make the document available to a larger set of potential users through their browsers, allow users the convenience of accessing the document within a browser, optimize users' experience in working with the document through a specific software application, or provide a simpler opening procedure. | 10-28-2010 |
Puran Bora, Little Rock, AR US
Puran S. Bora, Little Rock, AR US
| Patent application number | Description | Published |
|---|---|---|
| 20080221030 | Inhibition of Wet Type Age Related Macular Degeneration (Amd) by Adiponectin or Acrp 30 - The present invention provides new methods of treating wet type of age related macular degeneration by administering adiponectin (APN) or a functional fragment derived therefrom. One of the pathological complications of age related macular degeneration (AMD) is choroidal angiogenesis or choroidal neovascularization (CNV). The inventors discovered that the level of APN expression is significantly lower in the choroids of the laser-induced mouse model of choroidal angiogenesis or choroidal neovascularization (CNV) than that of the control mice and that administration of recombinant adiponectin (rAPN) or a peptide derived from the globular domain of the intact APN protein to the mouse model of CNV reduced the size of CNV significantly. These studies are the first to demonstrate the inhibitory effect of adiponectin on choroidal angiogenesis and thus provide the basis for treating a condition or disease involving angiogenesis, particularly age related macular degeneration, with administration of adiponectin. | 09-11-2008 |
| 20120041074 | Method of inducing neovascularization - A method for inducing neovascularization in which a pharmaceutically effective amount of polyethylene glycol (PEG) is injected into the tissue of the subject for purposes of accelerating wound healing and mimicking age related macular degeneration, cancer, tumors, and atherosclerosis for further research purposes. | 02-16-2012 |
Rajesh Onkardas Bora, Aurangabad IN
| Patent application number | Description | Published |
|---|---|---|
| 20090247478 | Novel macrolides and ketolides having antimicrobial activity - The present invention provides compounds having antimicrobial activity for preventing and treating diseases caused by microbial infections. Thus, the present invention relates to novel semi-synthetic 11,12-γ lactone macrolides and ketolides having antimicrobial activity, processes for making compounds as well as pharmaceutical compositions containing said compounds as active ingredients and methods of treating microbial infections with the compounds. | 10-01-2009 |
Rajesh Onkardas Bora, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20120309770 | Compounds for the Treatment of Hepatitis C - The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV. | 12-06-2012 |
Swapnil Bora, Plano, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20130063042 | Wireless lighting control system - A lighting device includes a DC/DC power converter, a controller/processor electrically connected to the DC/DC power converter, a light emitting diode (LED) current control circuit communicably coupled to the controller/processor and electrically connected to the DC/DC power converter, and two or more LEDs comprising at least a first color LED and a second color LED electrically connected to the LED current control circuit. The LED current control circuit provides an on/off signal having a cycle time to each LED in response to one or more control signals received from the controller/processor such that the two or more LEDs produce a blended light having a specified color based on how long each LED is turned ON and/or OFF during the cycle time. | 03-14-2013 |